Maridea Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Maridea Wealth Management's LLY Position: Q2 2026 in Review
Maridea Wealth Management increased its Eli Lilly (LLY) stake by 15% in Q2 2026, buying an estimated $53.1K and bringing the position to 406 shares worth $487K. The position accounts for 0.05% of the portfolio, ranked #307.
Maridea Wealth Management first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $724K in Q4 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Maridea Wealth Management held 406 shares of Eli Lilly worth $487K as of Q2 2026.
- Maridea Wealth Management bought 52 Eli Lilly shares in Q2 2026, an estimated $53.1K.
- Eli Lilly made up 0.05% of Maridea Wealth Management's portfolio in Q2 2026, its #307 holding.
- Maridea Wealth Management first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
- Maridea Wealth Management's Eli Lilly position peaked at $724K in Q4 2025.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Maridea Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.